Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-26-006553

Director bought 2,000 shares at $5.00 ($10,000)

From the SEC's structured data for this filing

Trades in this filing

Fisher Michal · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-18 Purchase : show line 1 in the form +2,000 $5.00 $10,000 2,000 D
Open-market purchases · 2,000 sh · avg $5.00 · $10,000
Loading xslF345X06/ownership.xml…